- Home
- ARQ vs MCRB Comparison
ARQ vs MCRB Comparison
Compare ARQ & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQ
- MCRB
- Stock Information
- Founded
- ARQ 1996
- MCRB 2010
- Country
- ARQ United States
- MCRB United States
- Employees
- ARQ N/A
- MCRB N/A
- Industry
- ARQ
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- ARQ
- MCRB Health Care
- Exchange
- ARQ NYSE
- MCRB Nasdaq
- Market Cap
- ARQ 147.8M
- MCRB 141.9M
- IPO Year
- ARQ N/A
- MCRB 2015
- Fundamental
- Price
- ARQ $3.65
- MCRB $10.08
- Analyst Decision
- ARQ Strong Buy
- MCRB Hold
- Analyst Count
- ARQ 1
- MCRB 5
- Target Price
- ARQ $9.00
- MCRB $80.00
- AVG Volume (30 Days)
- ARQ 284.1K
- MCRB 128.1K
- Earning Date
- ARQ 05-07-2025
- MCRB 05-07-2025
- Dividend Yield
- ARQ N/A
- MCRB N/A
- EPS Growth
- ARQ N/A
- MCRB N/A
- EPS
- ARQ N/A
- MCRB 0.02
- Revenue
- ARQ $108,959,000.00
- MCRB N/A
- Revenue This Year
- ARQ $19.26
- MCRB N/A
- Revenue Next Year
- ARQ $24.97
- MCRB N/A
- P/E Ratio
- ARQ N/A
- MCRB $575.90
- Revenue Growth
- ARQ 9.86
- MCRB N/A
- 52 Week Low
- ARQ $3.34
- MCRB $7.18
- 52 Week High
- ARQ $8.26
- MCRB $30.60
- Technical
- Relative Strength Index (RSI)
- ARQ 38.82
- MCRB 44.43
- Support Level
- ARQ $3.58
- MCRB $7.18
- Resistance Level
- ARQ $3.86
- MCRB $10.55
- Average True Range (ATR)
- ARQ 0.27
- MCRB 1.72
- MACD
- ARQ 0.05
- MCRB -0.03
- Stochastic Oscillator
- ARQ 56.36
- MCRB 46.63
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.